PIDS recently announced its strong support of universal masking for all school staff and students 2 years of age and older, as well as vaccination against COVID-19 for all eligible, in line with recommendations from the American Academy of Pediatrics for the beginning of the 2021-2022 school year. The Society’s statement was issued July 28. PIDS also recently joined more than…
A new clinical practice guideline issued by the American Academy of Pediatrics addresses questions related to evaluating otherwise well-appearing infants between 8-60 days old who develop a fever. The guideline breaks down recommendations for evaluation and care, and ranks the quality of available evidence. Risks and benefits also are detailed, including those concerning invasive procedures…
David Hyun, MD, is the director of the Antibiotic Resistance Project at The Pew Charitable Trusts, a non-profit, non-partisan policy research organization. The Antibiotic Resistance Project conducts research and advocacy that support policies that remove regulatory obstacles and create economic incentives for the innovation of new antibiotics and ensure antibiotic stewardship in healthcare and animal…
PIDS has extended the deadline for the research funding opportunity for fellows and junior faculty who identify as underrepresented in medicine (UIM) to October 8, 2021. Additional details on this opportunity are available at the PIDS Foundation website: https://pidsfoundation.org/awards/academic-pediatric-initiative-on-diversity/. As previously announced, we have partnered with the American Pediatric Association for the 2022 Research in Academic…
This was a week for celebration. Across the United States, new pediatric infectious diseases fellows began their training. Please join me in extending a warm welcome to the newest members of our PID community. While I hope all have joined the Pediatric Infectious Diseases Society and are receiving this newsletter, I realize that might not…
Fully updated for COVID-19 and accessible on Android devices for the first time, the latest version of the Vaccine Handbook App, a comprehensive, practical resource for information about vaccination and vaccine-preventable diseases, is now available. The app provides free, easy access to the full content of the upcoming 10th edition of The Vaccine Handbook: A…
At its recent meeting, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted unanimously to recommend use of a three-dose dengue vaccine for children 9 to 16 years old who live in endemic areas, such as Puerto Rico. Made by Sanofi Pasteur, the vaccine, Dengvaxia, protects against disease caused by all…
Update on Myocarditis Following COVID-19 Immunization PIDS On Call is a new initiative of PIDS that uses a webinar-based format to bring important clinical issues within pediatric infectious diseases to PIDS members. In this month’s PIDS On Call, Drs. Judy Guzman-Cottrill and Buddy Creech discussed what is known, and yet unknown, about myopericarditis in children following receipt of…
A dengue vaccine candidate had 62.0% efficacy against the illness and 83.6% efficacy against hospitalized dengue in children and adolescents, according to recently reported trial results. The data comes from an ongoing phase 3 study of Takeda Pharmaceutical’s TAK-003 candidate vaccine, which showed continued protection against dengue illness and hospitalization, regardless of previous dengue exposure,…
Two recent reports highlighted the concerning drop in routine child and adolescent vaccinations during the pandemic and the risk of outbreaks of vaccine-preventable diseases. An analysis of immunization information systems data from 10 U.S. jurisdictions found a substantial decrease in administered vaccine doses from March to May 2020 compared with same period in 2018 and…
Following increases in respiratory syncytial virus (RSV) activity in parts of the U.S., public health officials are encouraging broader RSV testing among patients who present with acute respiratory illness who test negative for SARS-CoV-2. In a June 10 health advisory, the Centers for Disease Control and Prevention (CDC) noted that, since late March, increases in…
Dr. Angela Campbell is a Medical Officer at the Centers for Disease Control and Prevention and lead of the Multisystem Inflammatory Syndrome (MIS) Unit of the COVID-19 Epidemiology Task Force in the Respiratory Viruses Branch of the Division of Viral Diseases, National Center for Immunization and Respiratory Diseases. Dr. Campbell completed her medical degree at…
Improving the health of children worldwide through philanthropic support of scientific and educational programs.
